Boomers have a vested interest in finding solutions to forthcoming long-term care crisis
NATIONAL REPORTS- People are living longer but not necessarily healthier lives than in decades past. The aging of America has prompted the Department of Health and Human Services (HHS) to grant $36 million to 28 states to help older Americans, veterans and those with Alzheimer's to remain in their homes.
About $19 million of this funding involves a new collaboration with the U.S. Department of Veterans Affairs (VA).
"The average senior is being treated for three chronic conditions, and with the diabetes explosion, that number will likely rise," says Brian T. Sullivan, vice president, Martin J Wolff & Co Inc., a Los Angeles insurance agency. "The incentives to create funding for home care are just common sense. We do not have enough room in existing nursing facilities, and of course the care can be rendered much more cost effectively."
LONG-TERM CARE NEEDS
HHS' Administration on Aging (AoA) will provide $10.5 million while states will provide $5.7 million for this new initiative that the AoA will administer in collaboration with the Veterans Health Administration. VA estimates purchasing at least $3 million in services. The number of veterans over age 85 has tripled during the past decade, creating a significant need for long-term care.
"Implications for executives will depend whether they are in the long-term care business or not," Sullivan says.
Most are not. Boomers own a huge share of assets, and finding solutions for the emerging long-term-care crisis is something they should focus on, he says.
Long-term care is still in its infancy, Sullivan believes. "A natural fit is a product that starts out as a disability plan in the earning, younger years and transitions to a long-term-care plan later in life. That way, they can create and keep customers for life," he says.
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Most Patients With HS Aren’t Aware of Approved Treatments
May 1st 2025Treating hidradenitis suppurativa is complex and often requires taking a number of medications, including antibiotics, hormone therapies and immunosuppressants. However, many of these treatments are used off-label, and at this time, only two biologic therapies—Humira (adalimumab) and Cosentyx (secukinumab)— are approved by the FDA for HS treatment.
Read More